Medicare names first 10 drugs up for price negotiations with the government

Lawrence Gostin, director of the O’Neill Institute for National and Global Health Law at Georgetown University, said it’s important to note that these negotiations are cumulative, meaning many more drugs will appear on the list within a few years.

Read more here.